Last reviewed · How we verify

NCT01786434: FEKOL

Routine or On-demand Fentanyl in Colonoscopy

Completed NA Last updated 6 April 2022
What this trial tests

NA trial testing Routine medication arm in Pain in 119 participants. Completed in 1 July 2015.

Timeline
10 December 2012
Primary endpoint
1 July 2015
1 July 2015

Quick facts

Lead sponsorSorlandet Hospital HF
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment119
Start date10 December 2012
Primary completion1 July 2015
Estimated completion1 July 2015
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Sorlandet Hospital HF

Who can join

Adults 18 to 75, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Colonoscopy may be an unpleasant procedure. Sedation and/or analgesics is therefore routinely administered in most countries. In Norway, however, routine sedation is rare, and medication is normally given on demand, that is, if necessary during the procedure. The investigators want to evaluate whether the effect of fentanyl, a synthetic opioid with fast onset of action, is better given before the procedure than during the procedure.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Routine vs. on-demand analgesia in colonoscopy: a randomized clinical trial.
    Holme Ø, de Lange T, Stallemo A, Wiig H, et al · · 2016 · cited 2× · PMID 27305424 · DOI 10.1055/s-0042-108433

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Sorlandet Hospital HF trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01786434.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing